Mohammad Sajjad Rahnama'i

Dr. Mohammad Sajjad Rahnama'i

Uniklinik RWTH Aachen, 52074 Aachen, Germany
orcid

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 April 2021 in Neurourology and Urodynamics
Verified
Journal Article
Closed access
PDF file
HFHelena Frawley
Helena Frawley
BSBeth Shelly
Beth Shelly
MMMélanie Morin
Mélanie Morin
SBStéphanie Bernard
Stéphanie Bernard
KBKari Bø
Kari Bø
JGJenniffer Voelkl Guevara
Jenniffer Voelkl Guevara

9 April 2021 in Frontiers in Surgery
Verified
Journal Article
Open access
PDF file
Mohammad Sajjad Rahnama'iMohammad Sajjad Rahnama'i
Mohammad Sajjad Rahnama'i
TMTom Marcelissen
Tom Marcelissen
BGBogdan Geavlete
Bogdan Geavlete
MTManuela Tutolo
Manuela Tutolo
THTanja Hüsch
Tanja Hüsch
Prostate cancer is the second most common cancer in men worldwide. Radical prostatectomy and radiation beam therapy are the most common treatment options for localized prostate cancer and have different associated complications. The etiology of post prostatectomy incontinence is multifactorial. There is evidence in the literature that anatomic support and pelvic innervation are important factors in the etiology of post-prostatectomy incontinence. Among the many surgical and technical factors proposed in the literature, extensive dissection during surgery, damage to the neurovascular bundle and the development of postoperative fibrosis have a substantial negative impact on the continence status of men undergoing RP. Sparing of the bladder neck and anterior, and possibly posterior, fixation of the bladder-urethra anastomosis are associated with better continence rates. Overactive bladder syndrome (OAB) is multifactorial and the exact role of prostate surgery in the development of OAB is still under debate. There are several variables that could contribute to detrusor overactivity. Detrusor overactivity in patients after radical prostatectomy has been mainly attributed to a partial denervation of the bladder during surgery. However, together with bladder denervation, other hypotheses, such as the urethrovesical mechanism, have been described. Although there is conflicting evidence regarding the importance of conservative treatment after post-prostatectomy urinary incontinence, pelvic floor muscle training (PFMT) is still considered as the first treatment choice. Duloxetin, either alone or in combination with PFMT, may hasten recovery of urinary incontinence but is often associated with severe gastrointestinal and central nervous side effects. However, neither PFMT nor duloxetine may cure male stress urinary incontinence. The therapeutic decision and the chosen treatment option must be individualized for each patient according to clinical and social factors. During the recent years, the development of new therapeutic choices such as male sling techniques provided a more acceptable management pathway for less severe forms of urinary incontinence related to radical prostatectomy. Following this perspective, technological improvements and the emergence of new dedicated devices currently create the premises for a continuously positive evolution of clinical outcomes in this particular category of patients.

1 March 2020 in European Urology Focus
Verified
Journal Article
Closed access
TATiago Antunes-Lopes
Tiago Antunes-Lopes
LVLuis Vale
Luis Vale
ACAna Margarida Coelho
Ana Margarida Coelho
CSCarlos Silva
Carlos Silva
MRMalte Rieken
Malte Rieken
TMTom Marcelissen
Tom Marcelissen

25 April 2017 in Neurourology and Urodynamics
Verified
Journal Article
Closed access
PDF file
MDMarcus Drake
Marcus Drake
NMNicola Morris
Nicola Morris
AAApostolos Apostolidis
Apostolos Apostolidis
Mohammad Sajjad Rahnama'iMohammad Sajjad Rahnama'i
Mohammad Sajjad Rahnama'i
JMJulian Marchesi
Julian Marchesi

31 March 2010 in Journal of Urology
Verified
Journal Article
Closed access
Mohammad Sajjad Rahnama'iMohammad Sajjad Rahnama'i
Mohammad Sajjad Rahnama'i
GKGommert A. van Koeveringe
Gommert A. van Koeveringe
PEPaul B. Essers
Paul B. Essers
SWStefan G.G. de Wachter
Stefan G.G. de Wachter
JVJan de Vente
Jan de Vente
GJGillespie J
Gillespie J
Purpose: Urothelium has 2 main functions. It is a barrier to urine and has a sensory role. In response to stretch urothelium releases various substances that modulate afferent nerve activity. Recent data on the localization of cyclooxygenase type 1, the enzyme responsible for prostaglandin production, suggests that prostaglandin may have complex local action. Materials and Methods: The bladders of 7 guinea pigs were stained for prostaglandin receptors type 1 and 2, and costained for vimentin and cyclooxygenase I. Results: Prostaglandin receptor type 1 staining was seen in urothelial cells and in the suburothelium. Urothelial staining, which was often punctuate and weak, was detected in all urothelial cell layers, including suburothelial cells. In contrast, strong prostaglandin receptor type 2 staining was seen in the urothelium and in suburothelial cells. Cyclooxygenase I was absent in interstitial cells and umbrella cells with the highest concentration in the basal cell layer. Conclusions: Interstitial cells express prostaglandin receptor types 1 and 2, indicating that they can respond to prostaglandin. Umbrella cells do not express cyclooxygenase I. Cyclooxygenase I was present in basal urothelial cells, making them a possible site of prostaglandin synthesis. Thus, prostaglandin produced by urothelium may target prostaglandin receptor types 1 and 2 in the urothelium and suburothelium. Therefore prostaglandin is hypothesized to have a role in signal regulation in the bladder wall.

13 March 2012 in Nature Reviews Urology
Verified
Journal Article
Closed access
Mohammad Sajjad Rahnama'iMohammad Sajjad Rahnama'i
Mohammad Sajjad Rahnama'i
PKPhilip E. V. van Kerrebroeck
Philip E. V. van Kerrebroeck
SWStefan G. de Wachter
Stefan G. de Wachter
GKGommert A. van Koeveringe
Gommert A. van Koeveringe